Maya Clinicals Launching drug development platform developing therapeutics in HIV in India

New Delhi, Sep 29, 2015
Maya, ten year old Clinical research organization founded in the epicenter for biotech, San Francisco, bay area and with hub in India to utilize global resources and make drug development more efficient.

Maya is built on a unique model tapping into expertise, accessing the vast talent pool across continents minimizing the costs and maximizing the productivity.

Maya is launching a novel drug development platform in HIV and infectious diseases with compounds originated by world class scientists and with access to cutting edge technology.

Maya wants to bring the compounds and latest technology to India and work on developing drugsfor indications with unmet medical need to benefit patients in India and across the globe.

Maya CEOJhansi Reddy is traveling in India with renowned veteran HIV development expert Dr. Marcus Conant, honored and respected pioneer, lecturer, physician and out-spoken advocate for people infected with HIV and AIDS. Among the first physicians to identify AIDS in 1981, he helped create one of the largest private AIDS clinics, was a founder of the San Francisco AIDS Foundation, and his work contributed to development of some of today’s top HIV medications.

They are meeting with the HIV and infectious diseases specialists in India at reputed research organizations to discuss and launch a collaborative therapeutic platform bringing the cutting edge technology and develop drugs in India on novel Maya platform

Also they are accompanied by Maya partner,Dr. V. P. Rao, well known entrepreneur, scientist, founder of Biogenesis, active player in bringing awareness in prevention of cancer, making a difference in geriatrics and healthy aging.
Corporate Comm India (CCI Newswire)